Aden K. Chan

Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Tai Chi versus brisk walking in reducing cardiovascular risk factors: a randomised controlled trial (abridged secondary publication).

Tai Chi versus brisk walking in reducing cardiovascular risk factors: a randomised controlled trial (abridged secondary publication).

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: June 14, 2022

Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication.

Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication.

Journal: Frontiers in oncology
Published: December 19, 2021

Establishment and characterization of meningioma patient-derived organoid.

Establishment and characterization of meningioma patient-derived organoid.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: July 14, 2021

Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas.

Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 16, 2021

Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas.

Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas.

Journal: Clinical neurology and neurosurgery
Published: March 26, 2021

Clinical and mutational profiles of adult medulloblastoma groups.

Clinical and mutational profiles of adult medulloblastoma groups.

Journal: Acta neuropathologica communications
Published: October 10, 2020

Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.

Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 17, 2020

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks.

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks.

Journal: Neuro-oncology advances
Published: November 01, 2019

IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations.

IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations.

Journal: Brain pathology (Zurich, Switzerland)
Published: June 05, 2019

Pediatric low-grade gliomas can be molecularly stratified for risk.

Pediatric low-grade gliomas can be molecularly stratified for risk.

Journal: Acta neuropathologica
Published: December 21, 2017

Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9.

Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: December 01, 2017

Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.

Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.

Journal: Neuro-oncology
Published: September 07, 2017
Showing 1-12 of 28

Last Updated: 09/26/2026